Business
TempraMed Strengthens Global Intellectual Property Position with Granted Chinese Patent for Newest Product, VIVI Box
Grant in China marks a major milestone in global IP strategy, advancing protection of its VIVI Box platform across key international marketsHighlightsChinese patent officially granted by CNIPA on March 17, 2026Covers core innovations underpinning TempraMed's VIVI Box™ multi-medication storage platform expected to market end of 2026Strengthens the Company's intellectual property position in one of the world's largest healthcare and consumer marketsSupports commercialization strategy and strategic
About this update from Tempramed Technologies Ltd.
[{"type":"text","content":"Grant in China marks a major milestone in global IP strategy, advancing protection of its VIVI Box platform across key international markets","length":140,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Chinese patent officially granted by CNIPA on March 17, 2026","length":60,"tagName":"p"}]},{"val":[{"type":"text","content":"Covers core innovations underpinning TempraMed's VIVI Box™ multi-medication storage platform expected to market end of 2026","length":127,"tagName":"p"}]},{"val":[{"type":"text","content":"Strengthens the Company's intellectual property position in one of the world's largest healthcare and consumer markets","length":126,"tagName":"p"}]},{"val":[{"type":"text","content":"Supports commercialization strategy and strategic engagement with appliance manufacturers across Asia's premium refrigeration sector","length":136,"tagName":"p"}]},{"val":[{"type":"text","content":"Patent term extends through October 23, 2039, with 44 claims granted","length":68,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":517,"olType":false},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - March 24, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that its Chinese patent application No. 202310499587.4 (the "Patent") has now been formally granted by the China National Intellectual Property Administration (CNIPA).","length":474,"tagName":"p"},{"type":"text","content":"The Patent, filed on October 24, 2019, was granted on March 17, 2026. The Patent includes claims covering key aspects of the Company's first of its kind, multi-medication storage box, VIVI Box™ which the Company is planning to launch to market at the end of 2026. Once launched it will add to the existing portfolio of four products being sold in market. There are also many commercial application opportunities with the VIVI Box™ which the Company has started exploring.","length":475,"tagName":"p"},{"type":"text","content":"Without limiting the scope of the patent, it includes core eleme...